The COVID-19 pandemic is far from over, caused by severe acute respiratory disease. Coronavirus2 continues to impact people’s health and well-being worldwide significantly, and vaccination is the only way to stop the spread. As vaccines are developed, one of the Indian government’s major challenges is vaccine adoption. The Indian government and policymakers should develop a plan to encourage and build trust in people for vaccine benefits. This study aims to identify the major issues acting as a barrier to vaccine hesitancy using primary data obtained in India between January-March 2021. This study shows that the 76% respondents were ready to accept the vaccine if it is available to them while 24% were hesitant. The study has investigated the association of demographic and geographical information of people with vaccines acceptance. The study has found that older people were more likely to accept the vaccines in comparison to  young adults. A significant difference in vaccine acceptance due to  the participants belonging to rural/urban areas is also observed. Additionally, we also noted that the educated people and working professionals were more likely to accept the vaccine than others. The study’s findings may be beneficial to the government in developing efficient vaccination acceptance strategies for the Indian populace.

COVID-19, vaccination, Indian citizens, policymakers, hesitancy.

Received: January 5, 2022; Revised: March 23, 2022; Accepted: April 6, 2022; Published: July 20, 2022

How to cite this article: Jitendra Sharma, Santosh Shrivastav and Sapna Tyagi, Factors determining COVID-19 vaccine acceptance: an empirical investigation from India, Advances and Applications in Statistics 79 (2022), 25-54. http://dx.doi.org/10.17654/0972361722058

This Open Access Article is Licensed under Creative Commons Attribution 4.0 International License

References:

[1] Y. A. Adebisi, A. J. Alaran, O. A. Bolarinwa, W. Akande-Sholabi and D. E. Lucero-Prisno, When available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria, 2020, medRxiv.
[2] A. K. Agarwal, A. Sengar, P. Gupta and R. Mahore, ‘MR Vaccine Campaign in India’ Get ahead Success, 2019.
[3] S. K. Agarwal and M. Naha, COVID-19 Vaccine Hesitancy in India: An Exploratory Analysis, medRxiv, 2021.
[4] A. Agrawal, S. Kolhapure, A. Di Pasquale, J. Rai and A. Mathur, Vaccine hesitancy as a challenge or vaccine confidence as an opportunity for childhood immunisation in India, Infectious Diseases and Therapy 9 (2020), 421-432.
[5] A. Alsaeedi and M. Z. Khan, A study on sentiment analysis techniques of Twitter data, International Journal of Advanced Computer Science and Applications 10(2) (2019), 361-374.
[6] R. M. Anderson, H. Heesterbeek, D. Klinkenberg and T. D. Hollingsworth, How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet 395(10228) (2020), 931-934.
[7] S. Aranganayagi and K. Thangavel, Clustering categorical data using silhouette coefficient as a relocating measure, International Conference on Computational Intelligence and Multimedia Applications (ICCIMA 2007), IEEE, Vol. 2, 2007, pp. 13-17.
[8] M. F. Arefi and M. Poursadeqiyan, A review of studies on the epidemic crisis of COVID-19 disease with a preventive approach, Work (Preprint), 2020, pp. 1-13.
[9] V. Arya, A. Page, J. River, G. Armstrong and P. Mayer, Trends and socio-economic determinants of suicide in India: 2001-2013, Social Psychiatry and Psychiatric Epidemiology 53(3) (2018), 269-278.
[10] S. Bagcchi, The world’s largest COVID-19 vaccination campaign, The Lancet Infectious Diseases 21(3) (2021), 323.
[11] S. Bahl, R. Kumar, N. Menabde, A. Thapa, J. McFarland, V. Swezy, and S. L. Cochi, Polio-free certification and lessons learned-South-East Asia region, MMWR, Morbidity and Mortality Weekly Report 63(42) (2014), 941.
[12] T. Beleche, J. Ruhter, A. Kolbe, J. Marus, L. Bush and B. D. Sommers, COVID-19 vaccine hesitancy: demographic factors, geographic patterns, and changes over time, ASPE 27 (2021), 1-27.
[13] H. R. Bhojwani, Developing innovative capacity in India to meet health needs, Innovation, Developing Countries to Meet Health Needs, 2005, 112.
[14] K. Black, Business Statistics: for Contemporary Decision Making, John Wiley & Sons, 2019.
[15] C. Chakraborty and G. Agoramoorthy, India’s cost-effective COVID-19 vaccine development initiatives, Vaccine 38(50) (2020), 7883.
[16] C. Chakraborty, A. R Sharma, M. Bhattacharya, G. Agoramoorthy and S. S. Lee, The current second wave and COVID-19 vaccination status in India, Brain, Behavior, and Immunity 96 (2021), 1-4.
[17] G. Chaturvedi, The Vital Drop: Communication for Polio Eradication in India. SAGE Publications India, 2008.
[18] L. Corey, J. R. Mascola, A. S. Fauci and F. S. Collins, A strategic approach to COVID-19 vaccine R&D, Science 368(6494) (2020), 948-950.
[19] K. G. M. Danabal, S. S. Magesh, S. Saravanan and V. Gopichandran, Attitude towards COVID-19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India - a community based survey, BMC Health Services Research 21(1) (2021), 1-10.
[20] A. Fisher, S. Mbaeyi and A. Cohn, Commentary: Addressing Vaccine Hesitancy in the Age of COVID-19, Academic Pediatrics, 2021.
[21] B. S. Graham, Rapid COVID-19 vaccine development, Science 368(6494) (2020), 945-946.
[22] J. Griffith, H. Marani and H. Monkman, COVID-19 Vaccine hesitancy in canada: content analysis of tweets using the theoretical domains framework, Journal of Medical Internet Research 23(4) (2021), e26874.
[23] I. Gupta and M. Bhatia, The Indian health care system, 2018.
[24] W. He, H. Wu, G. Yan, V. Akula and J. Shen, A novel social media competitive analytics framework with sentiment benchmarks, Information and Management 52(7) (2015), 801-812.
[25] M. S. Islam, A. H. M. Kamal, A. Kabir, D. L. Southern, S. H. Khan, S. M. Hasan, and H. Seale, COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence, PLoS One 16(5) (2021), e0251605.
[26] J. Jain, S. Saurabh, A. D. Goel, M. K. Gupta, P. Bhardwaj and P. R. Raghav, COVID-19 vaccine hesitancy among undergraduate medical students: results from a nationwide survey in India, medRxiv, 2021.
[27] A. Jurek, M. D. Mulvenna and Y. Bi, Improved lexicon-based sentiment analysis for social media analytics, Security Informatics 4(1) (2015), 1-13.
[28] S. Kashte, A. Gulbake, S. F. I. I. I. El-Amin and A. Gupta, COVID-19 vaccines: rapid development, implications, challenges and future prospects, Human Cell 34(3) (2021), 1-23.
[29] D. Kaul, COVID-19 vaccines: facts and controversies, Current Medicine Research and Practice 11(1) (2021), 1.
[30] A. Korzhenevych and M. Jain, Area-and gender-based commuting differentials in India’s largest urban-rural region, Transportation Research Part D: Transport and Environment 63 (2018), 733-746.
[31] N. Kühl, M. Goutier, A. Ensslen and P. Jochem, Literature vs. Twitter: empirical insights on customer needs in e-mobility, Journal of Cleaner Production 213 (2019), 508-520.
[32] V. M. Kumar, S. R. Pandi-Perumal, I. Trakht and S. P. Thyagarajan, Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases, npj Vaccines 6(1) (2021), 1-7.
[33] B. J. Kuter, S. Browne, F. M. Momplaisir, K. A. Feemster, A. K. Shen, J. Green-McKenzie and P. A. Offit, Perspectives on the receipt of a COVID-19 vaccine: a survey of employees in two large hospitals in Philadelphia, Vaccine 39(12) (2021), 1693-1700.
[34] J. V. Lazarus, S. C. Ratzan, A. Palayew, L. O. Gostin, H. J. Larson, K. Rabin and A. El-Mohandes, A global survey of potential acceptance of a COVID-19 vaccine, Nature Medicine 27(2) (2021), 225-228.
[35] T. T. Le, Z. Andreadakis, A. Kumar, R. G. Román, S. Tollefsen, M. Saville and S. Mayhew, The COVID-19 vaccine development landscape, Nat. Rev. Drug Discov. 19(5) (2020), 305-306.
[36] B. Lockyer, S. Islam, A. Rahman, J. Dickerson, K. Pickett, T. Sheldon and L. Sheard, Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK, 2020, medRxiv.
[37] N. Lurie, M. Saville, R. Hatchett and J. Halton, Developing COVID-19 vaccines at pandemic speed, New England Journal of Medicine 382(21) (2020), 1969-1973.
[38] N. E. MacDonald, Vaccine hesitancy: definition, scope and determinants, Vaccine 33(34) (2015), 4161-4164.
[39] S. Mukherjee and K. Pahan, Is COVID-19 gender-sensitive? Journal of Neuroimmune Pharmacology 16(1) (2021), 1-10.
[40] J. Murphy, F. Vallières, R. P. Bentall, M. Shevlin, O. McBride, T. K. Hartman and P. Hyland, Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom, Nature Communications 12(1) (2021), 1-15.
[41] V. Nikhra, Living with COVID-19: The Nemesis, the Hubris, and the Elpis, Dynamics 3 (2021), 012.
[42] T. V. Padma, India’s COVID-vaccine woes-by the numbers, Nature 592(7855) (2021), 500-501.
[43] H. S. Park and C. H. Jun, A simple and fast algorithm for K-medoids clustering, Expert Systems with Applications 36(2) (2009), 3336-3341.
[44] C. Pazzanese, Battling the ‘pandemic of misinformation, The Harvard Gazette, 2020.
[45] P. Pingali, A. Aiyar, M. Abraham and A. Rahman, Transforming food systems for a rising India, Springer Nature, 2019, p. 368.
[46] N. Pinto, R. Fadaak and M. Leslie, COVID-19 Vaccine Hesitancy Conversations: A Rapid Review of Resources Available to Primary Care Teams Across Canada, Canadian Family Physician, 2021.
[47] F. P. Polack, S. J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, W. C. Gruber, Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine, New England Journal of Medicine 383(27) (2020), 2603-2615.
[48] K. Priya, V. K. Pathak and A. K. Giri, Vaccination coverage and vaccine hesitancy among vulnerable population of India, Human Vaccines and Immunotherapeutics 16(7) (2020), 1502-1507.
[49] N. Puri, E. A. Coomes, H. Haghbayan and K. Gunaratne, Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases, Human Vaccines and Immunotherapeutics 16(11) (2020), 2586-2593.
[50] E. Robertson, K. S. Reeve, C. L. Niedzwiedz, J. Moore, M. Blake, M. Green and M. J. Benzeval, Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study, Brain, Behavior, and Immunity 94 (2021), 41-50.
[51] B. Rosen, R. Waitzberg, A. Israeli, M. Hartal and N. Davidovitch, Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel’s COVID-19 vaccination program, Israel Journal of Health Policy Research 10(1) (2021), 1-20.
[52] S. Saadat, D. Rawtani and C. M. Hussain, Environmental perspective of COVID-19, Science of the Total Environment Volume (2020), 138870.
[53] S. M. Saied, E. M. Saied, I. A. Kabbash and S. A. E. F. Abdo, Vaccine hesitancy: beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students, Journal of Medical Virology 93(7) (2021), 4280-4291.
[54] M. Schoch-Spana, Equity in Vaccination: A Plan to Work with Communities of Color toward COVID-19 Recovery and Beyond, Bloomberg School of Public Health, Johns Hopkins University, 2021.
[55] M. Schwarzinger, V. Watson, P. Arwidson, F. Alla and S. Luchini, COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics, The Lancet Public Health 6(4), (2021), e210-e221.
[56] P. Sharma and G. Pardeshi, Rollout of COVID-19 vaccination in India: a SWOT analysis, Disaster Medicine and Public Health Preparedness, 2021, pp. 1-4.
[57] Z. Tang, Z. Mei, G. Sui, and J. Zou, Visualizing the impact of COVID-19 on PM2, 5 concentrations in China, Regional Studies, Regional Science 8(1) (2021), 51-53.
[58] E. Vasileiou, C. R. Simpson, T. Shi, S. Kerr, U. Agrawal, A. Akbari, and A. Sheikh, Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study, The Lancet 397(10285), (2021), 1646-1657.
[59] A. L. Wagner, A. R. Shotwell, M. L. Boulton, B. F. Carlson, and J. L. Mathew, Demographics of vaccine hesitancy in Chandigarh, India, Frontiers in Medicine 7 (2021), 1062.
[60] S. L. Wilson and C. Wiysonge, Social media and vaccine hesitancy, BMJ Global Health 5(10) (2020), e004206.
[61] A. Wu, Y. Peng, B. Huang, X. Ding, X. Wang, P. Niu and T. Jiang, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host and Microbe 27(3) (2020), 325-328.
[62] A. Sharma and A. Srivastava, Perceptions and beliefs on vaccination for COVID-19 in Delhi: a cross-sectional study, Indian Journal of Medical Specialities 12(3) (2021), 151.
[63] P. Jeffrey Brantingham, G. E. Tita and G. Mohler, Gang‐related crime in Los Angeles remained stable following COVID‐19 social distancing orders, Criminology and Public Policy 20(3) (2021), 423-436.